Brainstorm Cell Therapeutics Research Coverage Started at StockNews.com

BCLI Stock  USD 1.73  0.02  1.17%   
Under 62% of Brainstorm Cell's investor base is looking to short. The analysis of the overall investor sentiment regarding Brainstorm Cell Therapeutics suggests that many traders are alarmed. Brainstorm Cell's investing sentiment shows overall attitude of investors towards Brainstorm Cell Therapeutics.
  
StockNews.com initiated coverage on shares of Brainstorm Cell Therapeutics in a research report report published on Wednesday. The brokerage issued a hold rating on the biotechnology companys stock. Separately, Maxim Group upgraded Brainstorm Cell Therapeutics from a hold rating to a buy rating and set a 2.00 price target on the

Read at thelincolnianonline.com
news
  

Brainstorm Cell Fundamental Analysis

We analyze Brainstorm Cell's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Brainstorm Cell using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Brainstorm Cell based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Brainstorm Cell is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Brainstorm Cell Ther Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Brainstorm Cell stock to make a market-neutral strategy. Peer analysis of Brainstorm Cell could also be used in its relative valuation, which is a method of valuing Brainstorm Cell by comparing valuation metrics with similar companies.

Peers

Brainstorm Cell Related Equities

TERNTerns Pharmaceuticals   3.41   
0%
28.0%
GRIGRI Bio   3.08   
0%
25.0%
CNTBConnect Biopharma   2.78   
0%
23.0%
EWTXEdgewise Therapeutics   1.33   
0%
11.0%
CRVSCorvus Pharmaceuticals   0.36   
0%
3.0%
CELCCelcuity LLC   0.71   
5.0%
0%
ALDXAldeyra   1.66   
13.0%
0%
PLXProtalix Biotherapeutics   1.80   
15.0%
0%
DAWNDay One   1.81   
15.0%
0%
MREOMereo BioPharma   2.20   
18.0%
0%
CUECue Biopharma   2.56   
21.0%
0%
TRVITrevi Therapeutics   2.80   
23.0%
0%
GBIOGeneration Bio   3.52   
29.0%
0%
BCABBioatla   4.79   
40.0%
0%
HOWLWerewolf Therapeutics   5.10   
42.0%
0%
XFORX4 Pharmaceuticals   5.13   
43.0%
0%
CCCCC4 Therapeutics   5.58   
46.0%
0%
INZYInozyme Pharma   6.09   
51.0%
0%
ANTXAN2 Therapeutics   6.25   
52.0%
0%
CKPTCheckpoint Therapeutics   6.26   
52.0%
0%
HCWBHCW Biologics   9.80   
82.0%
0%
PASGPassage Bio   11.88   
100.0%
0%

Complementary Tools for Brainstorm Stock analysis

When running Brainstorm Cell's price analysis, check to measure Brainstorm Cell's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brainstorm Cell is operating at the current time. Most of Brainstorm Cell's value examination focuses on studying past and present price action to predict the probability of Brainstorm Cell's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brainstorm Cell's price. Additionally, you may evaluate how the addition of Brainstorm Cell to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios